Haj Mohammad SF, van der Pol H, Vrdoljak E, Lassen U, Ojamaa K, Jalkanen K, Verlingue L, Stenzinger A, Patócs A, Curigliano G, Baltruškevičienė E, Helland Å, Russnes HG, Ługowska I, Mainoli B, Edsjö A, Lonardi E, Taskén K, Gelderblom H(2025) A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium ESMO Open, 10(11), 105872(in press) DOI 10.1016/j.esmoop.2025.105872, PubMed 41197434
Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS(2025) Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient Cell Death Dis, 16(1), 555 DOI 10.1038/s41419-025-07884-7, PubMed 40701968
Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA(2025) Targeting proteostasis in multiple myeloma through inhibition of LTK Leukemia, 39(9), 2237-2245 DOI 10.1038/s41375-025-02682-8, PubMed 40634511
